Long-term facial improvement after repeated BoNT-A injections and mirror biofeedback exercises for chronic facial synkinesis: a case-series study.

BACKGROUND Only few studies have considered the effects of the combined treatment with onabotulinumtoxinA (BoNT-A) injections and biofeedback (BFB) rehabilitation in the recovery of postparetic facial synkinesis (PPFS). AIM To explore the presence of a persistent improvement in facial function out of the pharmacological effect of BoNT-A in subjects with established PPFS, after repeated sessions of BoNT-A injections combined with an educational facial training program using mirror biofeedback (BFB) exercises. Secondary objective was to investigate the trend of the presumed persistent improvement. STUDY DESIGN Case-series study. SETTING Outpatient Clinic of Physical Medicine and Rehabilitation Unit. POPULATION Twenty-seven patients (22 females; mean age 45±16 years) affected by an established peripheral facial palsy, treated with a minimum of three BoNT-A injections in association with mirror BFB rehabilitation. The interval between consecutive BoNT-A injections was at least five months. METHODS At baseline and before every BoNT-A injection+mirror BFB session (when the effect of the previous BoNT-A injection had vanished), patients were assessed with the Italian version of Sunnybrook Facial Grading System (SB). The statistical analysis considered SB composite and partial scores before each treatment session compared to the baseline scores. RESULTS A significant improvement of the SB composite and partial scores was observed until the fourth session. Considering the "Symmetry of Voluntary Movement" partial score, the main improvement was observed in the muscles of the lower part of the face. CONCLUSIONS In a chronic stage of postparetic facial synkinesis, patients may benefit from a combined therapy with repeated BoNT-A injections and an educational facial training program with mirror BFB exercises, gaining an improvement of the facial function up to the fourth session. This improvement reflects the acquired ability to use facial muscle correctly. It doesn't involve the injected muscles but those trained with mirror biofeedback exercises and it persists also when BoNT-A action has vanished. CLINICAL REHABILITATION IMPACT The combined therapy with repeated BoNT-A injections and an educational facial training program using mirror BFB exercises may be useful in the motor recovery of the muscles of the lower part of the face not injected but trained.

[1]  E. D. Toffola,et al.  Platysma synkinesis in facial palsy and botulinum toxin type A , 2014, The Laryngoscope.

[2]  O. Ababneh,et al.  Long‐term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm , 2014, Clinical & experimental ophthalmology.

[3]  E. D. Toffola,et al.  Quantitative Measurement of Evolution of Postparetic Ocular Synkinesis Treated with Botulinum Toxin Type A , 2013, Plastic and reconstructive surgery.

[4]  Ki Hoon Choi,et al.  Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis. , 2013, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[5]  K. Cahill,et al.  Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome. , 2013, American journal of ophthalmology.

[6]  C. Tinelli,et al.  Validation of the Italian version of the Sunnybrook Facial Grading System , 2013, Neurological Sciences.

[7]  A. Múnera,et al.  Peripheral facial nerve lesions induce changes in the firing properties of primary motor cortex layer 5 pyramidal cells , 2012, Neuroscience.

[8]  Stefan Brodoehl,et al.  Time Course of Cortical Plasticity After Facial Nerve Palsy , 2012, Neurorehabilitation and neural repair.

[9]  N. Takeda,et al.  Mirror Biofeedback Rehabilitation after Administration of Single-Dose Botulinum Toxin for Treatment of Facial Synkinesis , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  Maria W G Nijhuis-van der Sanden,et al.  Frequency and Location of Synkineses in Patients With Peripheral Facial Nerve Paresis , 2010, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[11]  E. Prestifilippo,et al.  Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy , 2010, Disability and rehabilitation.

[12]  Bogdan Draganski,et al.  Training-induced structural changes in the adult human brain , 2008, Behavioural Brain Research.

[13]  J. Husseman,et al.  Management of synkinesis. , 2008, Facial plastic surgery : FPS.

[14]  R. Laskawi The use of botulinum toxin in head and face medicine: An interdisciplinary field , 2008, Head & face medicine.

[15]  B. Sessle,et al.  Neuroplasticity of face primary motor cortex control of orofacial movements. , 2007, Archives of oral biology.

[16]  S. Nakano,et al.  Low‐dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation , 2007, Acta neurologica Scandinavica.

[17]  Cristina Montomoli,et al.  Usefulness of BFB/EMG in facial palsy rehabilitation , 2005, Disability and rehabilitation.

[18]  N. O'dwyer,et al.  Reliability of the “Sydney,” “Sunnybrook,” and “House Brackmann” Facial Grading Systems to Assess Voluntary Movement and Synkinesis after Facial Nerve Paralysis , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[19]  M. Engström,et al.  Agreement between the Sunnybrook, House-Brackmann, and Yanagihara Facial Nerve Grading Systems in Bell’s Palsy , 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[20]  O. Suchowersky,et al.  Long‐term efficacy of botulinum toxin A in treatment of various movement disorders over a 10‐year period , 2002, Movement disorders : official journal of the Movement Disorder Society.

[21]  A. Berardelli,et al.  Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. , 2002, Archives of neurology.

[22]  W. Jost,et al.  Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm , 2001, Journal of Neurology.

[23]  S. Tiamkao,et al.  Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases , 1998, Journal of neurology, neurosurgery, and psychiatry.

[24]  J. Neely,et al.  Patterns of Facial Nerve Synkinesis , 1996, The Laryngoscope.

[25]  R. Laskawi,et al.  Botulinum toxin treatment in patients with facial synkinesis. , 1994, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery.

[26]  J. Nedzelski,et al.  Efficacy of feedback training in long‐standing facial nerve paresis , 1991, The Laryngoscope.

[27]  Ki Hoon Choi,et al.  Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis. , 2015, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[28]  C. Nduka,et al.  Quantitative analysis of normal smile with 3D stereophotogrammetry--an aid to facial reanimation. , 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[29]  R. Laskawi,et al.  Orbicular synkinesis after facial paralysis: Treatment with botulinum toxin , 2005, Documenta Ophthalmologica.

[30]  D. Dressler,et al.  BOTULINUM TOXIN Mechanisms of action , 2005 .

[31]  E. Stennert [The autoparalytic syndrome--a leading symptom of postparetic facial function]. , 1982, Archives of oto-rhino-laryngology.